Author:
Barry A. L.,Aldridge K. E.,Allen S. D.,Fuchs P. C.,Gerlach E. H.,Jones R. N.,Pfaller M. A.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference7 articles.
1. Franceschi, G., Foglio, M., Alpegiani, M., Battistini, C., Bedeschi, A., Perrone, E., Zarini, F., Arcamone, F. Synthesis and biological properties of sodium (5R, 6S, 8R)-6-hydroxylethyl-2-carboxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891. Journal of Antibiotics 1983, 36: 105–108.
2. Neu, H. C., Chin, N.-X., Labthavikul, P. The in vitro activity of a novel penem, FCE 22101, compared to otherβ-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1985, 16: 305–313.
3. Nord, C. E., Lindmark, A., Person, I. Susceptibility of anaerobic bacteria to FCE 22101. Antimicrobial Agents and Chemotherapy 1987, 31: 831–833.
4. Van der Auwera, P., Ernst, F., Grenier, P., Glupezynski, Y., Husson, M., Kastersky, J. In vitro activity of two carbapenems, FCE 22101 and CGP 31608, in comparison with imipenem. Journal of Antimicrobial Chemotherapy 1987, 20: 179–189.
5. Wise, R., Andrews, J. M., Danks, G. Comparison of in vitro activity of FCE 22101, a new penem, with those of otherβ-lactam antibiotics. Antimicrobial Agents and Chemotherapy 1983, 24: 909–914.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献